内科

目的评价医院人血白蛋白的临床应用情况，分析不合理的应用现状，探讨合理应用的办法。方法回顾性分析该院临床科室2014年4至6月人血白蛋白的应用情况对患者年龄、科室分布及用量、用药原因、用药前血清白蛋白浓度进行统计与分析。结果共28个临床科室使用人血白蛋白，涉及11类疾病，用量最大的主要是危重患者，疾病种类以肾病最多；个人用量以10～20 g居多；用药理由以肾病综合征所占比例最大，达19.75%；使用人血白蛋白前患者血清白蛋白分布主要集中在10～30 g·L-1。结论医院人血白蛋白存在一些不合理应用，需进一步规范人血白蛋白的使用。

ObjectiveTo evaluate the clinical application of human serum albumin in the hospital and to analyze the current situation of unreasonable utilization, then to provide reference for rational use of drug in the clinic. MethodsThe clinical application of human serum albumin in our hospital during April to Jun of 2014 was analyzed statistical retrospectively, and medical records were analyzed statistically in respect of age,department distribution,dosage,medication reason and the concentration of serum albumin before medication,etc. ResultsThe use of human serum albumin was widespread involving 28 clinical departments for 11 categories of diseases, with critical patients taking the lead in terms of patients, kidney disease topping the list in terms of consumption amount. Common individual consumption quantity ranged from 10-20 g. Most of patients adopted this drug for hypoproteinemia (19.75%), and most of them had a baseline serum albumin level at 10-30 goL-1 before using human serum albumin. ConclusionsThe clinical application of human serum albumin in our hospital is not reasonable enough, and need to further regulated.

ref